Table 2.
Molecular weight distribution of two ANE biostimulant treatments expressed as the average Mw of the main peaks, the Mw corresponding to the interval of the whole peak or the relative peak area.
| Treatment | # Peak | Peak properties1 | |||
|---|---|---|---|---|---|
| Average Mw (kDa) | Start Mw (kDa) | End Mw (kDa) | Area (%)2 | ||
| C129 | 1 | 212.12 ± 0.25 | 2,881.47 ± 2.34 | 3.11 ± 0.07 | 97.04 ± 0.56 |
| 2 | 2.32 ± 0.07 | 3.11 ± 0.07 | 1.67 ± 0.03 | 1.29 ± 0.04 | |
| 3 | 1.45 ± 0.04 | 1.67 ± 0.03 | 1.28 ± 0.03 | 0.47 ± 0.02 | |
| PSI-494 | 1 | 117.67 ± 0.18 | 2,676.67 ± 2.15 | 3.24 ± 0.11 | 91.19 ± 0.45* |
| 2 | 1.87 ± 0.05 | 3.24 ± 0.11 | 1.68 ± 0.03 | 6.65 ± 0.07* | |
| 3 | 1.44 ± 0.03 | 1.68 ± 0.03 | 1.29 ± 0.04 | 2.17 ± 0.03* | |
1
Data are the means ± SE (number biological replicates; n = 4).
2
The peak area was calculated in percentage over the total area of all peaks.
*
Differences between the respective peak area values of both ANEs were significant at p ≤ 0.001 (t-test).